InvestorsHub Logo
Followers 40
Posts 3318
Boards Moderated 0
Alias Born 08/18/2009

Re: None

Wednesday, 06/22/2016 4:22:25 PM

Wednesday, June 22, 2016 4:22:25 PM

Post# of 3881
CEO's own summary of the company at the close of his prez at JPM yesterday:

$130 million market cap
Dual Israeli and NASDQA listing (relatively new to NASDAQ)
3 Phase III's underway in US
all 3 are potential blockbusters
several Phase II programs underway
plenty of cash in the bank ($53 million as of Q1)
burn rate of $6-8m/Q
no debt
back by worlds's top healthcare investors
pharma deal in place already
multiple catalysts coming
aiming to become specialty pharma player in the US


Does it get any better than this in biotech investing?


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDHL News